LDL-APHERESIS WITH DEXTRAN SULFATE AND ANAPHYLACTOID REACTIONS TO ACE INHIBITORS

被引：35

作者：

KELLER, C

GRUTZMACHER, P

BAHR, F

SCHWARZBECK, A

KROON, AA

KIRAL, A

机构：

来源：

LANCET | 1993年 / 341卷 / 8836期

关键词：

D O I：

10.1016/0140-6736(93)92542-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：60 / 61

页数：2

共 6 条

[1] CAPTOPRIL - AN UPDATE OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN HYPERTENSION AND CONGESTIVE HEART-FAILURE [J].

BROGDEN, RN ;

TODD, PA ;

SORKIN, EM .

DRUGS, 1988, 36 (05) :540-600

[2] LDL-APHERESIS - RESULTS OF LONG-TERM TREATMENT AND VASCULAR OUTCOME [J].

KELLER, C .

ATHEROSCLEROSIS, 1991, 86 (01) :1-8

[3]

OLBRICHT, 1992, LANCET, V340, P908

[4] ENALAPRIL - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN HYPERTENSION AND CONGESTIVE-HEART-FAILURE [J].

TODD, PA ;

HEEL, RC .

DRUGS, 1986, 31 (03) :198-248

[5] COMPLEMENT ACTIVATION AND DEPLETION DURING LDL-APHERESIS BY HEPARIN-INDUCED EXTRACORPOREAL LDL-PRECIPITATION (HELP) [J].

WURZNER, R ;

SCHUFFWERNER, P ;

FRANZKE, A ;

NITZE, R ;

OPPERMANN, M ;

ARMSTRONG, VW ;

EISENHAUER, T ;

SEIDEL, D ;

GOTZE, O .

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1991, 21 (03) :288-294

[6]

YAMAMOTO A, 1992, ARTIF ORGANS, V16, P177

← 1 →